Latent Raises $80M Series A to Transform the Path from Diagnosis to Treatment Latent, a clinical AI company focused on accelerating access to life-saving medications, has announced the successful close…
Bridge Dental Group Expands California Presence with New Glendora Partnerships Bridge Dental Group has announced a significant step forward in its national growth strategy with the addition of two well-established…
Delcath Systems Secures Key Guideline Recognition for CHEMOSAT in Uveal Melanoma Treatment Delcath Systems, Inc., an interventional oncology company specializing in liver-directed cancer therapies, has announced a significant milestone for…
Community Health Systems Expands Community Impact Through Signature Giving Programs Community Health Systems continues to strengthen its commitment to the communities it serves through two of its most impactful annual…
AHF Calls for Equity-Driven Pandemic Agreement on World Health Day Marking World Health Day on April 7, AIDS Healthcare Foundation (AHF) issued a strong appeal for renewed global solidarity in…
Agenus to Present Phase II Data on Novel BOT+BAL and agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 Agenus a biotechnology company focused on advancing immuno-oncology therapies, has…
Powering PREVOYANCE® with Advanced Image Signal Processing Capabilities A correction has been issued regarding the original press release published on March 31, 2026. In the second paragraph, the certification previously…
SCP Health Expands Performance Edge Model to Strengthen Hospital-Based Care Hospitals across the United States are navigating an increasingly complex healthcare environment marked by workforce shortages, financial pressures, and rising…
Alpha Cognition Secures U.S. Patent for ALPHA-1062 in Traumatic Brain Injury, Expanding Pipeline Potential Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, has…
Frontier Medicines and LG Chem Forge Strategic Global Partnership for First-in-Class p53 Y220C Activator FMC-220 Frontier Medicines Corporation has entered into a landmark exclusive licensing agreement with LG Chem, Ltd.…
Dante Labs Genome Report Helps Single Mother Identify Her Children’s Rare Disease and Find Specialist Care A Mother’s Search for Answers For years, Susan lived with a quiet but persistent…
Emerging biotech advances novel platform to target previously “undruggable” epigenetic protein interfaces, aiming to develop precision therapies for pediatric brain cancers like DIPG TippingPoint Biosciences, an emerging player in the…